Caffeine prevents neurodegeneration and behavioral alterations in a mice model of agitated depression.

dc.contributor.authorMachado, Daniele Guilhermano
dc.contributor.authorLara, Marcus Vinicius Soares
dc.contributor.authorDobler, Paula Bruna
dc.contributor.authorAlmeida, Roberto Farina de
dc.contributor.authorPorciúncula, Lisiane de Oliveira
dc.date.accessioned2023-05-10T21:34:13Z
dc.date.available2023-05-10T21:34:13Z
dc.date.issued2020pt_BR
dc.description.abstractLongitudinal and some experimental studies have showed the potential of caffeine to counteract some depressive behaviors and synaptic dysfunctions. In this study, we investigated the potential of caffeine in preventing be- havioral outcomes, neurodegeneration and synaptic proteins alterations in a mice model of agitated depression by bilateral olfactory bulbectomy (OB). For this purpose, bulbectomized mice received caffeine (0.3 g/L and 1.0 g/L, drinking water), during the active cycle, for seven weeks (two before the surgery and throughout five weeks after OB). Caffeine prevented OBinduced hyperactivity and recognition memory impairment and rescue self care and motivational behavior. In the frontal cortex, bulbectomized mice presented increase in the ade- nosine A1 receptors (A1R) and GFAP, while adenosine A2A receptors (A2AR) increased in the hippocampus and striatum and SNAP-25 was decreased in frontal cortex and striatum. Caffeine increased A1R in the striatum of bulbectomized mice and in SHAM-water group caffeine increased A2AR in the striatum and decreased SNAP-25 in the frontal cortex. Astrogliosis observed in the polymorphic layer of the dentate gyrus of OB mice was pre- vented by caffeine as well as the neurodegeneration in the striatum and piriform cortex. Based on these beha- vioral and neurochemical evidences, caffeine confirms its efficacy in preventing neurodegeneration associated with memory impairment and may be considered as a promising therapeutic tool in the prophylaxis and/or treatment of depression.pt_BR
dc.identifier.citationMACHADO, D. G. et al. Caffeine prevents neurodegeneration and behavioral alterations in a mice model of agitated depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, v. 98, artigo 109776, mar. 2020. Disponível em: <https://www.sciencedirect.com/science/article/pii/S0278584619304828?via%3Dihub>. Acesso em: 11 out. 2022.pt_BR
dc.identifier.doihttps://doi.org/10.1016/j.pnpbp.2019.109776pt_BR
dc.identifier.issn1878-4216
dc.identifier.urihttp://www.repositorio.ufop.br/jspui/handle/123456789/16552
dc.identifier.uri2https://www.sciencedirect.com/science/article/pii/S0278584619304828?via%3Dihubpt_BR
dc.language.isoen_USpt_BR
dc.rightsrestritopt_BR
dc.subjectNeurodegenerationpt_BR
dc.subjectAdenosine receptorspt_BR
dc.subjectOlfactory bulbectomypt_BR
dc.subjectCaffeinept_BR
dc.subjectMemorypt_BR
dc.titleCaffeine prevents neurodegeneration and behavioral alterations in a mice model of agitated depression.pt_BR
dc.typeArtigo publicado em periodicopt_BR
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
ARTIGO_CaffeinePreventsNeurodegeneration.pdf
Tamanho:
11.51 MB
Formato:
Adobe Portable Document Format
Descrição:
Licença do Pacote
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: